Anthony Japour is an accomplished healthcare executive with extensive experience in medical and scientific consulting, clinical development, and corporate governance. Currently serving as the Chief Executive Officer at iTOLERANCE, Inc., Anthony also holds the position of Independent Director at Cocrystal Pharma, Inc., where involvement includes various committee roles. As the founder of Japour Enterprises, Anthony has been involved in strategic planning and public health policy consulting since 2002. Previous roles include leadership positions at AdvancedDx Biological Laboratories, ICON plc, and Abbott Laboratories, where significant contributions were made to drug development and commercialization efforts. Anthony holds a Doctor of Medicine from Northwestern University, a Post-Doctoral Fellowship in Infectious Diseases from Harvard Medical School, and a Bachelor of Science from the University of Michigan.